These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34436151)
1. Mechanisms of Azole Resistance and Trailing in Chen PY; Chuang YC; Wu UI; Sun HY; Wang JT; Sheng WH; Chen YC; Chang SC J Fungi (Basel); 2021 Jul; 7(8):. PubMed ID: 34436151 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420 [TBL] [Abstract][Full Text] [Related]
3. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates. Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565 [TBL] [Abstract][Full Text] [Related]
4. Dynamics of in vitro development of azole resistance in Candida tropicalis. Paul S; Singh S; Sharma D; Chakrabarti A; Rudramurthy SM; Ghosh AK J Glob Antimicrob Resist; 2020 Sep; 22():553-561. PubMed ID: 32339847 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis. Paul S; Shaw D; Joshi H; Singh S; Chakrabarti A; Rudramurthy SM; Ghosh AK PLoS One; 2022; 17(7):e0269721. PubMed ID: 35819969 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. Jiang C; Dong D; Yu B; Cai G; Wang X; Ji Y; Peng Y J Antimicrob Chemother; 2013 Apr; 68(4):778-85. PubMed ID: 23221625 [TBL] [Abstract][Full Text] [Related]
7. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
8. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates. Choi MJ; Won EJ; Shin JH; Kim SH; Lee WG; Kim MN; Lee K; Shin MG; Suh SP; Ryang DW; Im YJ Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550 [TBL] [Abstract][Full Text] [Related]
9. Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia. Sasani E; Yadegari MH; Khodavaisy S; Rezaie S; Salehi M; Getso MI Mycopathologia; 2021 Dec; 186(6):847-856. PubMed ID: 34410566 [TBL] [Abstract][Full Text] [Related]
10. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783 [TBL] [Abstract][Full Text] [Related]
11. Drug resistance genes and trailing growth in Candida albicans isolates. Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of virulence factors and azole resistance mechanisms of Jahanshiri Z; Manifar S; Hatami F Iran J Microbiol; 2023 Feb; 15(1):163-173. PubMed ID: 37069909 [TBL] [Abstract][Full Text] [Related]
13. Azole and echinocandin resistance mechanisms and genotyping of Candida tropicalis in Japan: cross-boundary dissemination and animal-human transmission of C. tropicalis infection. Khalifa HO; Watanabe A; Kamei K Clin Microbiol Infect; 2022 Feb; 28(2):302.e5-302.e8. PubMed ID: 34687855 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates. Astvad KMT; Hare RK; Arendrup MC Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148 [TBL] [Abstract][Full Text] [Related]
15. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect. Marcos-Zambrano LJ; Gómez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J Clin Microbiol Infect; 2018 Dec; 24(12):1343.e1-1343.e4. PubMed ID: 30025834 [TBL] [Abstract][Full Text] [Related]
16. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect. Marcos-Zambrano LJ; Gómez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J Clin Microbiol Infect; 2020 Nov; 26(11):1589-1592. PubMed ID: 32712246 [TBL] [Abstract][Full Text] [Related]
17. Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis. Paul S; Dadwal R; Singh S; Shaw D; Chakrabarti A; Rudramurthy SM; Ghosh AK PLoS One; 2021; 16(1):e0245160. PubMed ID: 33439909 [TBL] [Abstract][Full Text] [Related]
18. The Risk Factors and Mechanisms of Azole Resistance of Leepattarakit T; Tulyaprawat O; Ngamskulrungroj P J Fungi (Basel); 2022 Sep; 8(10):. PubMed ID: 36294548 [TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates. Arastehfar A; Daneshnia F; Hafez A; Khodavaisy S; Najafzadeh MJ; Charsizadeh A; Zarrinfar H; Salehi M; Shahrabadi ZZ; Sasani E; Zomorodian K; Pan W; Hagen F; Ilkit M; Kostrzewa M; Boekhout T Med Mycol; 2020 Aug; 58(6):766-773. PubMed ID: 31828316 [TBL] [Abstract][Full Text] [Related]
20. The Role of UPC2 Gene in Azole-Resistant Candida tropicalis. Jiang C; Ni Q; Dong D; Zhang L; Li Z; Tian Y; Peng Y Mycopathologia; 2016 Dec; 181(11-12):833-838. PubMed ID: 27538831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]